Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: A study on antibody titre

Brain

Volumn 130, Issue 5, 2007, Pages 1235-1243

  Takahashi, Toshiyuki ^a   Fujihara, Kazuo ^a   Nakashima, Ichiro ^a   Misu, Tatsuro ^a   Miyazawa, Isabelle ^a   Nakamura, Masashi ^a   Watanabe, Shohei ^a   Shiga, Yusei ^a   Kanaoka, Chihiro ^b   Fujimori, Juichi ^c   Sato, Shigeru ^c   Itoyama, Yasuto ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Tohoku Welfare Pension Hospital   (Japan)

^c Konan Hospital   (Japan)

Author keywords

Anti aquaporin 4 antibody; Antibody titre; Clinical features; Neuromyelitis optica; NMO IgG

Indexed keywords

AQUAPORIN 4; AQUAPORIN 4 ANTIBODY; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; PROTEIN ANTIBODY; UNCLASSIFIED DRUG; AUTOANTIBODY; BIOLOGICAL MARKER;

ADULT; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; BRAIN DAMAGE; CEREBROSPINAL FLUID ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA ANALYSIS; DISEASE EXACERBATION; DISEASE FREE INTERVAL; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG MEGADOSE; EMBRYO; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; HUMAN CELL; IMMUNOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MYELOOPTIC NEUROPATHY; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; BLOOD; BRAIN; CEREBROSPINAL FLUID; CHI SQUARE DISTRIBUTION; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY; RECURRENT DISEASE; RISK; SPINAL CORD;

ADULT; AQUAPORIN 4; AUTOANTIBODIES; BIOLOGICAL MARKERS; BRAIN; CHI-SQUARE DISTRIBUTION; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; MAGNETIC RESONANCE IMAGING; MALE; METHYLPREDNISOLONE; MIDDLE AGED; NEUROMYELITIS OPTICA; RECURRENCE; RISK; SENSITIVITY AND SPECIFICITY; SPINAL CORD;

EID: 34249696440     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awm062     Document Type: Article

References (19)

1. Bergamaschi R. Importance of cerebrospinal fluid examination in differential diagnosis of Devic's neuromyelitis optica by multiple sclerosis. Neurol Sci 2003; 24: 95-6.
2. Jung JS, Bhat RV, Preston GM, Guggino WB, Baraban JM, Agre P. Molecular characterization of an aquaporin cDNA from brain: Candidate osmoreceptor and regulator of water balance. Proc Natl Acad Sci USA 1994; 91: 13052-6.
3. Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005; 202: 473-7.
4. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004; 364: 2106-12.
5. Lucchinetti CF, Mandler RN, McGravern D, Bruck W, Gleich G, Ransohoff RM, et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 2002; 125: 1450-61.
6. Misu T, Fujihara K, Nakashima I, Sato S, Itoyama Y. Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica. Neurology 2005a; 65: 1479-82.
7. Misu T, Kakita A, Fujihara K, Nakashima I, Takahashi H, Itoyama Y. A comparative neuropathological analysis of Japanese cases of neuromyelitis optica and multiple sclerosis. Neurology 2005b; 64 (Suppl. 1): A39.
8. Misu T, Fujihara K, Nakamura M, Murakami K, Endo M, Konno H, et al. Loss of Aquaporin-4 in active perivascular lesions in neuromyelitis optica: a case report. Tohoku J Exp Med 2006; 209: 269-75.
9. Misu T, Fujihara K, Kakita A, Konno H, Nakamura M, Watanabe S, et al. Loss of aquaporin-4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain 2007 (in press).
10. Nakashima I, Fujihara K, Miyazawa I, Misu T, Narikawa K, Nakamura M, et al. Clinical and MRI features of Japanese patients with multiple sclerosis for NMO-IgG. J Neurol Neurosurg Psychiatry 2006; 77: 1073-5.
11. Oshio K, Binder DK, Yang B, Schecter S, Verkman AS, Manley GT. Expression of aquaporin water channels in mouse spinal cord. Neuroscience 2004; 127: 685-93.
12. Pittock SJ, Lennon VA, Krecke K, Wingerchuk DM, Lucchinetti CF, Weinshenker BG. Brain abnormalities in neuromyelitis optica. Arch Neurol 2006a; 63: 390-6.
13. Pittock SJ, Weinshenker BG, Lucchinetti CF, Wingerchuk DM, Corboy JR, Lennon VA. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol 2006b; 63: 964-8.
14. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-31.
15. Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H, Bruck W, et al. Pattern-specific loss of aquaporin-4 immunoreativity distinguishes neuromyelitis optica from multiple sclerosis. Brain 2007 (in press).
16. Takahashi T, Fujihara K, Nakashima I, Misu T, Miyazawa I, Nakamura M, et al. Establishment of a new sensitive assay for anti-human aquaporin-4 antibody in neuromyelitis optica. Tohoku J Exp Med 2006; 210: 307-13.
17. Vizuete ML, Venero JL, Vargas C, Ilundain AA, Echevarria M, Machado A, et al. Differential upregulation of aquaporin-4 mRNA expression in reactive astrocytes after brain injury: potential role in brain edema. Neurobiol Dis 1999; 6: 245-58.
18. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 1999; 53: 1107-14.
19. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006; 66: 1485-9.